Gemina Laboratories Ltd.
GLAB
Rank in Stocks
#35736
Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the... Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the research, development, and commercialization of in-vitro diagnostics. The firm invents innovative surface functionalization chemistries for identifying pathogens and biomarkers. Among its current projects, Gemina is advancing the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip specifically designed to detect active COVID-19 infections. The company maintains its headquarters in Vancouver, Canada.
Share Price
$0.04377166
Last synced: 2026-02-05
Market Cap
$3.35M
Change (1 day)
-0.30%
Change (1 year)
-81.04%
Country
CA
Trade Gemina Laboratories Ltd. (GLAB)
Category
Healthcare
Market Capitalization of Gemina Laboratories Ltd.(GLAB)
Market Cap: $3.35M
As of October 2026 Gemina Laboratories Ltd. has a market cap of $3.35M. This makes Gemina Laboratories Ltd. the world's 35736th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Gemina Laboratories Ltd. from 2022 to 2026
GLAB compared with Top 5 Most Popular stocks
